Alnylam Pharmace. buy melinda
Summary
This prediction ended on 10.11.17 with a price of €125.50. The prediction had a final performance of 22.22%. melinda has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Alnylam Pharmace. | -0.853% | -0.853% | 51.803% | 45.341% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
According to melinda what are the pros and cons of Alnylam Pharmace. for the foreseeable future?
Pros
Cons
Comments by melinda for this prediction
In the thread Alnylam Pharmace. diskutieren
pharma
Stopped prediction by melinda for Alnylam Pharmace.
Alnylam Pharmace.
16.10.21
16.10.22
24.10.21
Alnylam Pharmace.
27.11.19
04.11.21
16.10.21
Alnylam Pharmace.
28.09.18
22.01.19
22.01.19
Alnylam Pharmace.
12.03.18
13.09.18
13.09.18
Alnylam Pharmace.
16.11.17
12.03.18
12.03.18
Alnylam Pharmace.
20.09.17
10.11.17
10.11.17
Alnylam Pharmace.
09.09.17
20.09.17
20.09.17
Alnylam Pharmace.
09.09.17
20.09.17
20.09.17
Alnylam Pharmace.
24.09.13
24.03.14
24.03.14